EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Fecal microbiota transplantation in patients with Clostridioides difficile Infection following COVID-19: A case series

Anna Bryczkowska-Folga, Adrianna Bok-Wojtanowska, Tomasz Arłukowicz

Polish Annals of Medicine · 03.08.2026 · 33 · 225-230

DOI: 10.31648/paom/224829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Annals of Medicine, online erschienen am 03.08.2026. Verfasst von Anna Bryczkowska-Folga und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

During the COVID-19 pandemic, a marked increase in the incidence of Clostridioides Difficile Infection (CDI) was observed in Poland. This trend has been associated with widespread antibiotic use and healthcare burden during the SARS-CoV-2 pandemic. High disease severity, frequent recurrences, and limited therapeutic options continue to make CDI a significant clinical challenge.

Aim

To describe the clinical course and outcomes of Fecal Microbiota Transplantation (FMT) in patients with Clostridioides Difficile Infection following COVID-19. Material and methods This retrospective case series included four adult patients who developed CDI shortly after COVID-19. All patients underwent FMT between April and August 2021. Three patients experienced at least two severe recurrences before FMT, whereas one patient with fulminant CDI underwent FMT after the first episode. Clinical outcomes were assessed based on symptom resolution and absence of recurrence during follow-up. Results and Discussion All patients experienced resolution of diarrhea and gastrointestinal symptoms following FMT. No CDI recurrences were observed during follow-up. No procedure-related complications were reported. Although limited by the small sample size, heterogeneous study population, and retrospective design, the findings suggest that FMT may be a feasible therapeutic option in selected patients with severe or recurrent CDI following COVID-19.

Conclusions

In this small retrospective case series, Fecal Microbiota Transplantation was associated with favorable clinical outcomes and absence of CDI recurrence during follow-up in patients with severe or recurrent CDI following COVID-19.

Zitieren

APA

Bryczkowska-Folga, A., Bok-Wojtanowska, A., & Arłukowicz, T. (2026). Fecal microbiota transplantation in patients with Clostridioides difficile Infection following COVID-19: A case series. Polish Annals of Medicine, 33, 225-230. https://doi.org/10.31648/paom/224829

Vancouver

Bryczkowska-Folga A, Bok-Wojtanowska A, Arłukowicz T. Fecal microbiota transplantation in patients with Clostridioides difficile Infection following COVID-19: A case series. Polish Annals of Medicine. 2026;33:225-230. doi:10.31648/paom/224829

BibTeX
@article{BryczkowskaFolga2026,
  author = {Bryczkowska-Folga, Anna and Bok-Wojtanowska, Adrianna and Arłukowicz, Tomasz},
  title = {Fecal microbiota transplantation in patients with Clostridioides difficile Infection following COVID-19: A case series},
  journal = {Polish Annals of Medicine},
  year = {2026},
  volume = {33},
  pages = {225--230},
  doi = {10.31648/paom/224829}
}
Kostenlos starten →